# Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis

> **NCT04990128** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **COMBINATION_PRODUCT:** Aspire Needle + Emcyte PureBMC
- **DRUG:** Triamcinolone

## Key facts

- **NCT ID:** NCT04990128
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2027-07
- **Final completion:** 2027-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990128, "Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04990128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*